These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 31964348)

  • 21. Evaluation of screening and treatment of cryptococcal antigenaemia among HIV-infected persons in Soweto, South Africa.
    Govender NP; Roy M; Mendes JF; Zulu TG; Chiller TM; Karstaedt AS
    HIV Med; 2015 Sep; 16(8):468-76. PubMed ID: 25689352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cryptococcal meningitis in children: description of 3 cases].
    Ndiaye M; Diagne NR; Seck LB; Sow AD; Sène MS; Diop AG; Sow HD; Ndiaye MM
    Med Trop (Mars); 2011 Apr; 71(2):176-8. PubMed ID: 21695878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRYPTOCOCCAL meningitis in a HIV negative newly diagnosed diabetic patient: a CASE report.
    Owuor OH; Chege P
    BMC Infect Dis; 2019 Jan; 19(1):5. PubMed ID: 30606110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cryptococcal immune reconstitution inflammatory syndrome.
    Longley N; Harrison TS; Jarvis JN
    Curr Opin Infect Dis; 2013 Feb; 26(1):26-34. PubMed ID: 23242412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.
    Boyd MA; Amin J; Mallon PW; Kumarasamy N; Lombaard J; Wood R; Chetchotisakd P; Phanuphak P; Mohapi L; Azwa I; Belloso WH; Molina JM; Hoy J; Moore CL; Emery S; Cooper DA;
    Lancet HIV; 2017 Jan; 4(1):e13-e20. PubMed ID: 27815068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The immunopathogenesis of cryptococcal immune reconstitution inflammatory syndrome: understanding a conundrum.
    Meya DB; Manabe YC; Boulware DR; Janoff EN
    Curr Opin Infect Dis; 2016 Feb; 29(1):10-22. PubMed ID: 26658650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recurrence of cryptococcal meningitis in HIV-infected patients following immune reconstitution.
    Seddon J; Mangeya N; Miller RF; Corbett EL; Ferrand RA
    Int J STD AIDS; 2009 Apr; 20(4):274-5. PubMed ID: 19304977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shedding light on IRIS: from Pathophysiology to Treatment of Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome in HIV-Infected Individuals.
    Balasko A; Keynan Y
    HIV Med; 2019 Jan; 20(1):1-10. PubMed ID: 30362282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fatal cryptococcal meningitis in an AIDS patient complicated with immune reconstitution syndrome refractory to prolonged amphotericin B treatment.
    Bandaranayake TD; Ogbuagu OE; Mahajan A; Vortmeyer AO; Villanueva MS
    Int J STD AIDS; 2018 Oct; 29(12):1250-1254. PubMed ID: 29749873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and laboratory features of cryptococcal meningitis in HIV-AIDS patients.
    Deo S
    J Assoc Physicians India; 1995 Oct; 43(10):724. PubMed ID: 8773019
    [No Abstract]   [Full Text] [Related]  

  • 31. Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study).
    Echeverría P; Negredo E; Carosi G; Gálvez J; Gómez JL; Ocampo A; Portilla J; Prieto A; López JC; Rubio R; Mariño A; Pedrol E; Viladés C; del Arco A; Moreno A; Bravo I; López-Blazquez R; Pérez-Alvarez N; Clotet B
    Antiviral Res; 2010 Feb; 85(2):403-8. PubMed ID: 19941906
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of vitiligo occurring after initiation of antiretroviral treatment and disappearing during this treatment: autoimmune IRIS syndrome?].
    Defo D; Kouotou EA; Bissek AC; Mboua JB
    Ann Dermatol Venereol; 2012 Nov; 139(11):736-8. PubMed ID: 23199771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
    Maher D; Mwandumba H
    J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Switching to lopinavir/ritonavir with or without abacavir/lamivudine in lipoatrophic patients treated with zidovudine/abacavir/lamivudine.
    Bernardino JI; Pulido F; Martinez E; Arrizabalaga J; Domingo P; Portilla J; Ocampo A; Muñoz J; Torres R; Arribas JR;
    J Antimicrob Chemother; 2013 Jun; 68(6):1373-81. PubMed ID: 23386261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meningitis due to a combined infection with Cryptococcus neoformans and Streptococcus pneumoniae in an AIDS patient.
    John MA; Coovadia Y
    J Infect; 1998 Mar; 36(2):231-2. PubMed ID: 9570664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abacavir/lamivudine/zidovudine maintenance after standard induction in antiretroviral therapy-naïve patients: FREE randomized trial interim results.
    Sprenger HG; Langebeek N; Mulder PG; Ten Napel CH; Vriesendorp R; Hoepelman AI; Legrand JC; Koopmans PP; Van Kasteren ME; Bravenboer B; Ten Kate RW; Groeneveld PH; van der Werf TS; Gisolf EH; Richter C
    AIDS Patient Care STDS; 2010 Jun; 24(6):361-6. PubMed ID: 20515418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.
    Boyd MA; Moore CL; Molina JM; Wood R; Madero JS; Wolff M; Ruxrungtham K; Losso M; Renjifo B; Teppler H; Kelleher AD; Amin J; Emery S; Cooper DA;
    Lancet HIV; 2015 Feb; 2(2):e42-51. PubMed ID: 26424460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.
    Lakoh S; Rickman H; Sesay M; Kenneh S; Burke R; Baldeh M; Jiba DF; Tejan YS; Boyle S; Koroma C; Deen GF; Beynon F
    BMC Infect Dis; 2020 Feb; 20(1):141. PubMed ID: 32059703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution.
    Bicanic T; Harrison T; Niepieklo A; Dyakopu N; Meintjes G
    Clin Infect Dis; 2006 Oct; 43(8):1069-73. PubMed ID: 16983622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
    Rugemalila J; Maro VP; Kapanda G; Ndaro AJ; Jarvis JN
    Trop Med Int Health; 2013 Sep; 18(9):1075-1079. PubMed ID: 23937699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.